Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Parallel Comparison of Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)

NCT04979130 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT04979130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04979130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Parallel Comparison of Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2022
Completion date
October 16, 2024
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammation, intestinal permeability, type 2 diabetes